Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative hemin safety study for prevention of acute kidney injury after on-pump cardiac surgery
2013-004607-39Phase 2Completed
- Sponsor
- Erasmus Hospital
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of heme arginate in acute kidney failure (AKF) (2 arms), sponsored by Erasmus Hospital. Primary endpoints: Incidence of hemin-related side effects and Incidence of other complications. Started Jan 2014; status: completed.
02
Drugs
heme arginate
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on 2013-004607-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004607-39.